APA (7th ed.) Citation

Onwah, S. S., Mou, Z., Gupta, G., Obi, P., Ikeogu, N., Jia, P., . . . Uzonna, J. (2025). Leishmania major Dihydrolipoyl dehydrogenase (DLD) is a key metabolic enzyme that drives parasite proliferation, pathology and host immune response. PLoS Pathogens, 21(3), 1. https://doi.org/10.1371/journal.ppat.1012978

Chicago Style (17th ed.) Citation

Onwah, Somtochukwu S., et al. "Leishmania Major Dihydrolipoyl Dehydrogenase (DLD) Is a Key Metabolic Enzyme That Drives Parasite Proliferation, Pathology and Host Immune Response." PLoS Pathogens 21, no. 3 (2025): 1. https://doi.org/10.1371/journal.ppat.1012978.

MLA (9th ed.) Citation

Onwah, Somtochukwu S., et al. "Leishmania Major Dihydrolipoyl Dehydrogenase (DLD) Is a Key Metabolic Enzyme That Drives Parasite Proliferation, Pathology and Host Immune Response." PLoS Pathogens, vol. 21, no. 3, 2025, p. 1, https://doi.org/10.1371/journal.ppat.1012978.